Cargando…

Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan

OBJECTIVE: Recently, the national diagnostic reference levels (DRLs) in Japan were revised as the DRLs 2020, wherein the body weight-based injection dose optimization in positron emission tomography/computed tomography using (18)F-fluoro-2-deoxy-D-glucose ((18)F-FDG PET/CT) was first proposed. We re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagara, Hiroaki, Inoue, Kazumasa, Yaku, Hideki, Ohsawa, Amon, Someya, Takashi, Yanagisawa, Kaori, Ohashi, Shuhei, Ishigaki, Rikuta, Wakabayashi, Masashi, Muramatsu, Yoshihisa, Fujii, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494693/
https://www.ncbi.nlm.nih.gov/pubmed/34287782
http://dx.doi.org/10.1007/s12149-021-01656-x
_version_ 1784579369306423296
author Sagara, Hiroaki
Inoue, Kazumasa
Yaku, Hideki
Ohsawa, Amon
Someya, Takashi
Yanagisawa, Kaori
Ohashi, Shuhei
Ishigaki, Rikuta
Wakabayashi, Masashi
Muramatsu, Yoshihisa
Fujii, Hirofumi
author_facet Sagara, Hiroaki
Inoue, Kazumasa
Yaku, Hideki
Ohsawa, Amon
Someya, Takashi
Yanagisawa, Kaori
Ohashi, Shuhei
Ishigaki, Rikuta
Wakabayashi, Masashi
Muramatsu, Yoshihisa
Fujii, Hirofumi
author_sort Sagara, Hiroaki
collection PubMed
description OBJECTIVE: Recently, the national diagnostic reference levels (DRLs) in Japan were revised as the DRLs 2020, wherein the body weight-based injection dose optimization in positron emission tomography/computed tomography using (18)F-fluoro-2-deoxy-D-glucose ((18)F-FDG PET/CT) was first proposed. We retrospectively investigated the usefulness of this optimization method in improving image quality and reducing radiation dose. METHODS: A total of 1,231 patients were enrolled in this study. A fixed injection dose of 240 MBq was administered to 624 patients, and a dose adjusted to 3.7 MBq/kg body weight was given to 607 patients. The patients with body weight-based injection doses were further divided according to body weight: group 1 (≤ 49 kg), group 2 (50–59 kg), group 3 (60–69 kg), and group 4 (≥ 70 kg). The effective radiation dose of FDG PET was calculated using the conversion factor of 0.019 mSv/MBq, per the International Commission on Radiological Protection publication 106. Image quality was assessed using noise equivalent count density (NEC(density)), which was calculated by excluding the counts of the brain and bladder. The usefulness of the injection dose optimization in terms of radiation dose and image quality was analyzed. RESULTS: The body weight-based injection dose optimization significantly decreased the effective dose by 11%, from 4.54 ± 0.1 mSv to 4.05 ± 0.8 mSv (p < 0.001). Image quality evaluated by NEC(density) was also significantly improved by 10%, from 0.39 ± 0.1 to 0.43 ± 0.2 (p < 0.001). In no case did NEC(density) deteriorate when the effective dose was decreased. In group 1, the dose decreased by 32%, while there was no significant deterioration in NEC(density) (p = 0.054). In group 2, the dose decreased by 17%, and the NEC(density) increased significantly (p < 0.01). In group 3, the dose decreased by 3%, and the NEC(density) increased significantly (p < 0.01). In group 4, the dose increased by 14%, but there was no significant change in the NEC(density) (p = 0.766). CONCLUSION: Body weight-based FDG injection dose optimization contributed to not only the reduction of effective dose but also the improvement of image quality in patients weighing between 50 and 69 kg.
format Online
Article
Text
id pubmed-8494693
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-84946932021-10-19 Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan Sagara, Hiroaki Inoue, Kazumasa Yaku, Hideki Ohsawa, Amon Someya, Takashi Yanagisawa, Kaori Ohashi, Shuhei Ishigaki, Rikuta Wakabayashi, Masashi Muramatsu, Yoshihisa Fujii, Hirofumi Ann Nucl Med Original Article OBJECTIVE: Recently, the national diagnostic reference levels (DRLs) in Japan were revised as the DRLs 2020, wherein the body weight-based injection dose optimization in positron emission tomography/computed tomography using (18)F-fluoro-2-deoxy-D-glucose ((18)F-FDG PET/CT) was first proposed. We retrospectively investigated the usefulness of this optimization method in improving image quality and reducing radiation dose. METHODS: A total of 1,231 patients were enrolled in this study. A fixed injection dose of 240 MBq was administered to 624 patients, and a dose adjusted to 3.7 MBq/kg body weight was given to 607 patients. The patients with body weight-based injection doses were further divided according to body weight: group 1 (≤ 49 kg), group 2 (50–59 kg), group 3 (60–69 kg), and group 4 (≥ 70 kg). The effective radiation dose of FDG PET was calculated using the conversion factor of 0.019 mSv/MBq, per the International Commission on Radiological Protection publication 106. Image quality was assessed using noise equivalent count density (NEC(density)), which was calculated by excluding the counts of the brain and bladder. The usefulness of the injection dose optimization in terms of radiation dose and image quality was analyzed. RESULTS: The body weight-based injection dose optimization significantly decreased the effective dose by 11%, from 4.54 ± 0.1 mSv to 4.05 ± 0.8 mSv (p < 0.001). Image quality evaluated by NEC(density) was also significantly improved by 10%, from 0.39 ± 0.1 to 0.43 ± 0.2 (p < 0.001). In no case did NEC(density) deteriorate when the effective dose was decreased. In group 1, the dose decreased by 32%, while there was no significant deterioration in NEC(density) (p = 0.054). In group 2, the dose decreased by 17%, and the NEC(density) increased significantly (p < 0.01). In group 3, the dose decreased by 3%, and the NEC(density) increased significantly (p < 0.01). In group 4, the dose increased by 14%, but there was no significant change in the NEC(density) (p = 0.766). CONCLUSION: Body weight-based FDG injection dose optimization contributed to not only the reduction of effective dose but also the improvement of image quality in patients weighing between 50 and 69 kg. Springer Singapore 2021-07-21 2021 /pmc/articles/PMC8494693/ /pubmed/34287782 http://dx.doi.org/10.1007/s12149-021-01656-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Sagara, Hiroaki
Inoue, Kazumasa
Yaku, Hideki
Ohsawa, Amon
Someya, Takashi
Yanagisawa, Kaori
Ohashi, Shuhei
Ishigaki, Rikuta
Wakabayashi, Masashi
Muramatsu, Yoshihisa
Fujii, Hirofumi
Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan
title Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan
title_full Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan
title_fullStr Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan
title_full_unstemmed Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan
title_short Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan
title_sort optimization of injection dose in (18)f-fdg pet/ct based on the 2020 national diagnostic reference levels for nuclear medicine in japan
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494693/
https://www.ncbi.nlm.nih.gov/pubmed/34287782
http://dx.doi.org/10.1007/s12149-021-01656-x
work_keys_str_mv AT sagarahiroaki optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan
AT inouekazumasa optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan
AT yakuhideki optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan
AT ohsawaamon optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan
AT someyatakashi optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan
AT yanagisawakaori optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan
AT ohashishuhei optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan
AT ishigakirikuta optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan
AT wakabayashimasashi optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan
AT muramatsuyoshihisa optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan
AT fujiihirofumi optimizationofinjectiondosein18ffdgpetctbasedonthe2020nationaldiagnosticreferencelevelsfornuclearmedicineinjapan